Ocular pharmacokinetics of tivozanib eye drops in patients with neovascular age-related macular degeneration: comparison with phase 1 trials of oral tivozanib in solid tumors.
- DOI
- 10.1186/s40942-026-00848-9
- Published
- 2026 Apr 15
- Container
- International journal of retina and vitreous
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s40942-026-00848-9,
title = {Ocular pharmacokinetics of tivozanib eye drops in patients with neovascular age-related macular degeneration: comparison with phase 1 trials of oral tivozanib in solid tumors.},
author = {Horita S and Saki M and Takigawa S and Kanai Y and Murotani K and Gomi F},
year = {2026},
journal = {International journal of retina and vitreous},
doi = {10.1186/s40942-026-00848-9},
url = {https://doi.org/10.1186/s40942-026-00848-9}
}RIS
TY - JOUR TI - Ocular pharmacokinetics of tivozanib eye drops in patients with neovascular age-related macular degeneration: comparison with phase 1 trials of oral tivozanib in solid tumors. AU - Horita S AU - Saki M AU - Takigawa S AU - Kanai Y AU - Murotani K AU - Gomi F PY - 2026 JO - International journal of retina and vitreous DO - 10.1186/s40942-026-00848-9 UR - https://doi.org/10.1186/s40942-026-00848-9 ER -
APA
S, H., M, S., S, T., Y, K., K, M., & F, G. (2026). Ocular pharmacokinetics of tivozanib eye drops in patients with neovascular age-related macular degeneration: comparison with phase 1 trials of oral tivozanib in solid tumors.. International journal of retina and vitreous. https://doi.org/10.1186/s40942-026-00848-9
Source records
- pubmed · retrieved 2026-09-26T17:14:59.927Z